Escalating pandemic risks are outpacing international readiness as the Global Preparedness Monitoring Board (GPMB) completes its eight-year mandate. The board demands an urgent shift from technical fixes to sustained political commitment and independent oversight, laying out a five-pillar blueprint to translate technical evidence into intergovernmental action.  BERLIN – A comprehensive review of global health reforms […] Continue reading ->
More sexual misconduct and abusive claims were filed against WHO staff than closed over the previous month – with 361 open cases in 2026, as of the beginning of September, according to the agency’s own investigations dashboard. In August, the last month reported, investigators opened 37 new sexual and abusive conduct cases and closed 25, […] Continue reading ->
China has nominated a prominent Chinese health official for WHO Director General in the 2027 elections, multiple diplomatic sources have confirmed to Health Policy Watch.  But there are mixed reports about who that candidate actually may be. Some high-level sources have cited Song Li, a senior Chinese Communist Party official who mounted a failed bid […] Continue reading ->
The Medicines Patent Pool (MPP) has signed sublicense agreements with 11 manufacturers across multiple regions to expand access to generic baloxavir marboxil, a single-dose antiviral treatment for influenza that was originally developed by Swiss pharmaceutical company Roche.  The announcement, made the night before last Friday’s UN High-Level Meeting on Pandemic Prevention, Preparedness and Response, reignited […] Continue reading ->
Several significant pledges for global health – covering reproductive health, ‘transition’ and Ebola – were made on the fringes of last week’s United Nations General Assembly amid massive donor withdrawal from the sector. Reproductive health, which has suffered massive funding losses, got a $337.8 million boost from the United Kingdom, which announced its pledge at […] Continue reading ->